{"id":"W4401363835","doi":"10.1093/oncolo/oyae181.036","title":"35 Efficacy of treatments post-lenvatinib in patients with advanced renal cell carcinoma (aRCC)","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University Medical Centre; Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Lenvatinib; Medicine; Cabozantinib; Internal medicine; Renal cell carcinoma; Oncology; Cohort; Pembrolizumab; Discontinuation; Sorafenib; Cancer; Hepatocellular carcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001386098,0.0002381118,0.0004013346,0.0001294779,0.00004430143,0.00001283693,0.000143903,0.00007573218,0.00008181796],"category_scores_gemma":[0.00003516411,0.0001237069,0.0001097598,0.0003429062,0.0002114369,0.0000560435,0.00005766137,0.000214546,0.00005414051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005052388,"about_ca_system_score_gemma":0.000240763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002308449,"about_ca_topic_score_gemma":0.0000444592,"domain_scores_codex":[0.9985867,0.0000752453,0.0003434871,0.000345907,0.0003513484,0.0002973006],"domain_scores_gemma":[0.9990057,0.0002468748,0.0001038924,0.0004694737,0.00008589659,0.00008818566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01270551,0.006081649,0.9011425,0.0004645911,0.0003718692,0.001344306,0.002416679,0.0002399534,0.01101695,0.0001633614,0.0007729565,0.0632797],"study_design_scores_gemma":[0.008699314,0.00952275,0.9663452,0.0001877189,0.0002963586,0.00001308024,0.0001199453,0.00003377668,0.0142286,0.00001620687,0.0004122997,0.0001247685],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854189,0.0007476309,0.000002846944,0.0004008851,0.0001032427,0.001212724,0.00003870367,0.00004911382,0.01202595],"genre_scores_gemma":[0.9978474,0.0000170703,0.0004838748,0.00009432295,0.00004291977,0.00007228942,0.0001440459,0.0000347483,0.001263345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0652027,"threshold_uncertainty_score":0.5044623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01513811120652536,"score_gpt":0.2673251085670865,"score_spread":0.2521869973605612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}